Furthermore, large‐scale meta‐analyses involving up to 24,000 patients treated with anti‐TNF agents found no evidence of significant renal toxicity, further reinforcing the safety of these therapies in individuals with CKD [27]. This evidence concerns the gene TNF and chronic kidney disease.